226 related articles for article (PubMed ID: 22334400)
1. Illegitimate V(D)J recombination involving nonantigen receptor loci in lymphoid malignancy.
Onozawa M; Aplan PD
Genes Chromosomes Cancer; 2012 Jun; 51(6):525-35. PubMed ID: 22334400
[TBL] [Abstract][Full Text] [Related]
2. Illegitimate V(D)J recombination-mediated deletions in Notch1 and Bcl11b are not sufficient for extensive clonal expansion and show minimal age or sex bias in frequency or junctional processing.
Champagne DP; Shockett PE
Mutat Res; 2014 Mar; 761():34-48. PubMed ID: 24530429
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the V(D)J recombination efficiency at lymphoid chromosomal translocation breakpoints.
Raghavan SC; Kirsch IR; Lieber MR
J Biol Chem; 2001 Aug; 276(31):29126-33. PubMed ID: 11390401
[TBL] [Abstract][Full Text] [Related]
4. V(D)J recombinase binding and cleavage of cryptic recombination signal sequences identified from lymphoid malignancies.
Zhang M; Swanson PC
J Biol Chem; 2008 Mar; 283(11):6717-27. PubMed ID: 18187418
[TBL] [Abstract][Full Text] [Related]
5. Involvement of illegitimate V(D)J recombination or microhomology-mediated nonhomologous end-joining in the formation of intragenic deletions of the Notch1 gene in mouse thymic lymphomas.
Tsuji H; Ishii-Ohba H; Katsube T; Ukai H; Aizawa S; Doi M; Hioki K; Ogiu T
Cancer Res; 2004 Dec; 64(24):8882-90. PubMed ID: 15604248
[TBL] [Abstract][Full Text] [Related]
6. Prevalent involvement of illegitimate V(D)J recombination in chromosome 9p21 deletions in lymphoid leukemia.
Kitagawa Y; Inoue K; Sasaki S; Hayashi Y; Matsuo Y; Lieber MR; Mizoguchi H; Yokota J; Kohno T
J Biol Chem; 2002 Nov; 277(48):46289-97. PubMed ID: 12228235
[TBL] [Abstract][Full Text] [Related]
7. Chimeric gamma-delta signal joints. Implications for the mechanism and regulation of T cell receptor gene rearrangement.
Tycko B; Coyle H; Sklar J
J Immunol; 1991 Jul; 147(2):705-13. PubMed ID: 1649221
[TBL] [Abstract][Full Text] [Related]
8. Control of antigen receptor diversity through spatial regulation of V(D)J recombination.
Ebert A; Medvedovic J; Tagoh H; Schwickert TA; Busslinger M
Cold Spring Harb Symp Quant Biol; 2013; 78():11-21. PubMed ID: 24584058
[TBL] [Abstract][Full Text] [Related]
9. V(D)J-mediated translocations in lymphoid neoplasms: a functional assessment of genomic instability by cryptic sites.
Marculescu R; Le T; Simon P; Jaeger U; Nadel B
J Exp Med; 2002 Jan; 195(1):85-98. PubMed ID: 11781368
[TBL] [Abstract][Full Text] [Related]
10. Spatial Regulation of V-(D)J Recombination at Antigen Receptor Loci.
Ebert A; Hill L; Busslinger M
Adv Immunol; 2015; 128():93-121. PubMed ID: 26477366
[TBL] [Abstract][Full Text] [Related]
11. Quantification of hprt gene deletions mediated by illegitimate V(D)J recombination in peripheral blood cells of humans.
Fuscoe JC; Vira LK; Collard DD; Moore MM
Environ Mol Mutagen; 1997; 29(1):28-35. PubMed ID: 9020304
[TBL] [Abstract][Full Text] [Related]
12. Chromatin Dynamics and the Development of the TCRα and TCRδ Repertoires.
Carico Z; Krangel MS
Adv Immunol; 2015; 128():307-61. PubMed ID: 26477370
[TBL] [Abstract][Full Text] [Related]
13. Breakpoint sites disclose the role of the V(D)J recombination machinery in the formation of T-cell receptor (TCR) and non-TCR associated aberrations in T-cell acute lymphoblastic leukemia.
Larmonie NS; Dik WA; Meijerink JP; Homminga I; van Dongen JJ; Langerak AW
Haematologica; 2013 Aug; 98(8):1173-84. PubMed ID: 23904235
[TBL] [Abstract][Full Text] [Related]
14. Frequent and sex-biased deletion of SLX4IP by illegitimate V(D)J-mediated recombination in childhood acute lymphoblastic leukemia.
Meissner B; Bartram T; Eckert C; Trka J; Panzer-Grümayer R; Hermanova I; Ellinghaus E; Franke A; Möricke A; Schrauder A; Teigler-Schlegel A; Dörge P; von Stackelberg A; Basso G; Bartram CR; Kirschner-Schwabe R; Bornhäuser B; Bourquin JP; Cazzaniga G; Hauer J; Attarbaschi A; Izraeli S; Zaliova M; Cario G; Zimmermann M; Avigad S; Sokalska-Duhme M; Metzler M; Schrappe M; Koehler R; Te Kronnie G; Stanulla M
Hum Mol Genet; 2014 Feb; 23(3):590-601. PubMed ID: 24045615
[TBL] [Abstract][Full Text] [Related]
15. Chromosome choice for initiation of V-(D)-J recombination is not governed by genomic imprinting.
Gebert C; Correia L; Li Z; Petrie HT; Love PE; Pfeifer K
Immunol Cell Biol; 2017 May; 95(5):473-477. PubMed ID: 28244489
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous Quantification of t(14;18) and HPRT Exon 2/3 Deletions in Human Lymphocytes.
Fuscoe JC
Methods Mol Biol; 2020; 2102():361-370. PubMed ID: 31989567
[TBL] [Abstract][Full Text] [Related]
17. Alterations in chromatin at antigen receptor loci define lineage progression during B lymphopoiesis.
Lion M; Muhire B; Namiki Y; Tolstorukov MY; Oettinger MA
Proc Natl Acad Sci U S A; 2020 Mar; 117(10):5453-5462. PubMed ID: 32098847
[TBL] [Abstract][Full Text] [Related]
18. An Ectopic CTCF Binding Element Inhibits Tcrd Rearrangement by Limiting Contact between Vδ and Dδ Gene Segments.
Chen L; Zhao L; Alt FW; Krangel MS
J Immunol; 2016 Oct; 197(8):3188-3197. PubMed ID: 27613698
[TBL] [Abstract][Full Text] [Related]
19. DNA sequence analysis of interlocus recombination between the human T-cell receptor gamma variable (GV) and beta diversity-joining (BD/BJ) sequences on chromosome 7 (inversion 7).
Ballinger SW; Judice SA; Nicklas JA; Albertini RJ; O'Neill JP
Environ Mol Mutagen; 2002; 40(2):85-92. PubMed ID: 12203400
[TBL] [Abstract][Full Text] [Related]
20. A human lymphoid leukemia cell line with a V(D)J recombinase-mediated deletion of hprt.
Chen CL; Woo MH; Neale GA; Goorha RM; Fuscoe JC; Behm FG; Mathew S; Relling MV
Mutat Res; 1998 Jul; 403(1-2):113-25. PubMed ID: 9726012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
